Ford HT - Search Results

1

Assessment of response of bone metastases to systemic treatment in patients with breast cancer.

Coombes RC, Dady P, Parsons C, McCready VR, Ford HT, Gazet JC, Powles TJ. Coombes RC, et al. Among authors: ford ht. Cancer. 1983 Aug 15;52(4):610-4. doi: 10.1002/1097-0142(19830815)52:4<610::aid-cncr2820520406>3.0.co;2-5. Cancer. 1983. PMID: 6861098

2

Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisolone.

Russell JA, Baker JW, Dady PJ, Ford HT, Gazet JC, McKinna JA, Nash AG, Powles TJ. Russell JA, et al. Among authors: ford ht. Cancer. 1978 Feb;41(2):396-9. doi: 10.1002/1097-0142(197802)41:2<396::aid-cncr2820410203>3.0.co;2-t. Cancer. 1978. PMID: 630530

3

Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.

Coombes RC, Berger U, Mansi J, Redding H, Powles TJ, Neville AM, McKinna A, Nash AG, Gazet JC, Ford HT, et al. Coombes RC, et al. Among authors: ford ht. NCI Monogr. 1986;(1):51-3. NCI Monogr. 1986. PMID: 3774015

4

Screening for metastases in breast cancer: an assessment of biochemical and physical methods.

Coombes RC, Powles TJ, Gazet JC, Ford HT, McKinna A, Abbott M, Gehrke CW, Keyser JW, Mitchell PE, Patel S, Stimson WH, Worwood M, Jones M, Neville AM. Coombes RC, et al. Among authors: ford ht. Cancer. 1981 Jul 15;48(2):310-5. doi: 10.1002/1097-0142(19810715)48:2<310::aid-cncr2820480216>3.0.co;2-v. Cancer. 1981. PMID: 6113047

5

Danazol treatment for advanced breast cancer.

Coombes RC, Perez D, Gazet JC, Ford HT, Powles TJ. Coombes RC, et al. Among authors: ford ht. Cancer Chemother Pharmacol. 1983;10(3):194-5. doi: 10.1007/BF00255761. Cancer Chemother Pharmacol. 1983. PMID: 6345017 Clinical Trial.

6

Use of an antiosteolytic agent in treatment of patients with bone metastases from breast cancer.

Dady PJ, Coombes RC, Smith IE, Parsons CA, Ford HT, Gazet JC, Henk JM, Nash AG, Powles TJ. Dady PJ, et al. Among authors: ford ht. Eur J Cancer (1965). 1980;Suppl 1:131-5. Eur J Cancer (1965). 1980. PMID: 6459234 No abstract available.

7

Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.

Harris AL, Powles TJ, Smith IE, Coombes RC, Ford HT, Gazet JC, Harmer CL, Morgan M, White H, Parsons CA, McKinna JA. Harris AL, et al. Among authors: ford ht. Eur J Cancer Clin Oncol. 1983 Jan;19(1):11-17. doi: 10.1016/0277-5379(83)90390-5. Eur J Cancer Clin Oncol. 1983. PMID: 6682769

8

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.

Coombes RC, Powles TJ, Rees LH, Ratcliffe WA, Nash AG, Henk M, Ford HT, Gazet JC, Neville AM. Coombes RC, et al. Among authors: ford ht. Br J Cancer. 1982 Jul;46(1):30-4. doi: 10.1038/bjc.1982.161. Br J Cancer. 1982. PMID: 7104195 Free PMC article.

9

Danazol treatment of advanced breast cancer.

Coombes RC, Dearnaley D, Humphreys J, Gazet JC, Ford HT, Nash AG, Mashiter K, Powles TJ. Coombes RC, et al. Among authors: ford ht. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1073-6. Cancer Treat Rep. 1980. PMID: 7459893

10

Biochemical markers in human breast cancer.

Coombes RC, Powles TJ, Gazet JC, Ford HT, Sloane JP, Laurence DJ, Neville AM. Coombes RC, et al. Among authors: ford ht. Lancet. 1977 Jan 15;1(8003):132-4. doi: 10.1016/s0140-6736(77)91719-6. Lancet. 1977. PMID: 64663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page